This research proposes a new mechanism through which HF-MSC-Exo promotes chronic skin wound repair, indicating that lncRNA H19 and exosomes could be a therapeutic strategy for diabetes focal skin defects. This evidence concerns the gene H19 and diabetes mellitus.